COMPANY

Intelligent Bio Solutions

HQ: New York, NY source · ibs.inc ↗ · Mid-Atlantic

Location: New York, NY · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $4.98M (Form D filed Sep 14, 2026). SEC Form D 0001725430-26-000002 (Sep 14, 2026)
Evidence (1 event)
- Sep 14, 2026 · SEC Form D 0001725430-26-000002
  Name of Issuer: INTELLIGENT BIO SOLUTIONS INC.; CIK: 1725430; Address: New York, NY; Submission type: D; Filing date: 2026-09-14; Industry Group: Other Health Care; Date of First Sale: 2026-08-31; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 4979631; Total Amount Sold: 4979631; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Dec 31, 2025 Raise Private placement: $10M (total, as published), announced Dec 31, 2025. Source: SEC filing. source ↗ · Form D filed Jan 13, 2026 SEC Form D ↗
Feb 21, 2025 Raise Follow-on offering: $3M (total, as published), announced Feb 21, 2025. Source: SEC filing. source ↗

Raised: $13.0M. Last 2 years.

Dec 31, 2025 Private placement: $10M (total, as published), announced Dec 31, 2025. Source: SEC filing. source ↗ · Form D filed Jan 13, 2026 SEC Form D ↗
Feb 21, 2025 Follow-on offering: $3M (total, as published), announced Feb 21, 2025. Source: SEC filing. source ↗